vs

Side-by-side financial comparison of ASGN Inc (ASGN) and CABOT CORP (CBT). Click either name above to swap in a different company.

ASGN Inc is the larger business by last-quarter revenue ($970.0M vs $849.0M, roughly 1.1× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs 0.6%, a 8.0% gap on every dollar of revenue. On growth, ASGN Inc posted the faster year-over-year revenue change (-3.0% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $9.1M). Over the past eight quarters, ASGN Inc's revenue compounded faster (-3.2% CAGR vs -8.7%).

ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

ASGN vs CBT — Head-to-Head

Bigger by revenue
ASGN
ASGN
1.1× larger
ASGN
$970.0M
$849.0M
CBT
Growing faster (revenue YoY)
ASGN
ASGN
+8.1% gap
ASGN
-3.0%
-11.1%
CBT
Higher net margin
CBT
CBT
8.0% more per $
CBT
8.6%
0.6%
ASGN
More free cash flow
CBT
CBT
$47.9M more FCF
CBT
$57.0M
$9.1M
ASGN
Faster 2-yr revenue CAGR
ASGN
ASGN
Annualised
ASGN
-3.2%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ASGN
ASGN
CBT
CBT
Revenue
$970.0M
$849.0M
Net Profit
$5.5M
$73.0M
Gross Margin
27.5%
24.9%
Operating Margin
2.9%
15.2%
Net Margin
0.6%
8.6%
Revenue YoY
-3.0%
-11.1%
Net Profit YoY
-73.7%
-21.5%
EPS (diluted)
$0.13
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASGN
ASGN
CBT
CBT
Q1 26
$970.0M
Q4 25
$980.1M
$849.0M
Q3 25
$1.0B
$899.0M
Q2 25
$1.0B
$923.0M
Q1 25
$968.3M
$936.0M
Q4 24
$985.0M
$955.0M
Q3 24
$1.0B
$1.0B
Q2 24
$1.0B
$1.0B
Net Profit
ASGN
ASGN
CBT
CBT
Q1 26
$5.5M
Q4 25
$25.2M
$73.0M
Q3 25
$38.1M
$43.0M
Q2 25
$29.3M
$101.0M
Q1 25
$20.9M
$94.0M
Q4 24
$42.4M
$93.0M
Q3 24
$47.5M
$137.0M
Q2 24
$47.2M
$109.0M
Gross Margin
ASGN
ASGN
CBT
CBT
Q1 26
27.5%
Q4 25
28.9%
24.9%
Q3 25
29.4%
24.5%
Q2 25
28.7%
26.4%
Q1 25
28.4%
25.7%
Q4 24
29.0%
24.6%
Q3 24
29.1%
24.0%
Q2 24
29.1%
25.2%
Operating Margin
ASGN
ASGN
CBT
CBT
Q1 26
2.9%
Q4 25
5.7%
15.2%
Q3 25
6.7%
15.2%
Q2 25
5.8%
18.1%
Q1 25
4.8%
17.3%
Q4 24
7.5%
16.2%
Q3 24
7.7%
15.0%
Q2 24
7.8%
16.9%
Net Margin
ASGN
ASGN
CBT
CBT
Q1 26
0.6%
Q4 25
2.6%
8.6%
Q3 25
3.8%
4.8%
Q2 25
2.9%
10.9%
Q1 25
2.2%
10.0%
Q4 24
4.3%
9.7%
Q3 24
4.6%
13.7%
Q2 24
4.6%
10.7%
EPS (diluted)
ASGN
ASGN
CBT
CBT
Q1 26
$0.13
Q4 25
$0.58
$1.37
Q3 25
$0.87
$0.80
Q2 25
$0.67
$1.86
Q1 25
$0.48
$1.69
Q4 24
$0.94
$1.67
Q3 24
$1.06
$2.41
Q2 24
$1.02
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASGN
ASGN
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$143.6M
$230.0M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.8B
$1.6B
Total Assets
$4.0B
$3.8B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASGN
ASGN
CBT
CBT
Q1 26
$143.6M
Q4 25
$161.2M
$230.0M
Q3 25
$258.0M
Q2 25
$239.0M
Q1 25
$213.0M
Q4 24
$205.2M
$183.0M
Q3 24
$223.0M
Q2 24
$197.0M
Total Debt
ASGN
ASGN
CBT
CBT
Q1 26
$1.5B
Q4 25
$1.2B
Q3 25
$1.2B
$1.1B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.0B
Q3 24
$1.0B
$1.1B
Q2 24
$1.0B
Stockholders' Equity
ASGN
ASGN
CBT
CBT
Q1 26
$1.8B
Q4 25
$1.8B
$1.6B
Q3 25
$1.8B
$1.6B
Q2 25
$1.8B
$1.5B
Q1 25
$1.8B
$1.4B
Q4 24
$1.8B
$1.4B
Q3 24
$1.8B
$1.4B
Q2 24
$1.8B
$1.3B
Total Assets
ASGN
ASGN
CBT
CBT
Q1 26
$4.0B
Q4 25
$3.7B
$3.8B
Q3 25
$3.7B
$3.8B
Q2 25
$3.7B
$3.8B
Q1 25
$3.7B
$3.8B
Q4 24
$3.4B
$3.6B
Q3 24
$3.4B
$3.7B
Q2 24
$3.5B
$3.6B
Debt / Equity
ASGN
ASGN
CBT
CBT
Q1 26
0.82×
Q4 25
0.65×
Q3 25
0.64×
0.70×
Q2 25
0.66×
Q1 25
0.72×
Q4 24
0.58×
Q3 24
0.58×
0.75×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASGN
ASGN
CBT
CBT
Operating Cash FlowLast quarter
$126.0M
Free Cash FlowOCF − Capex
$9.1M
$57.0M
FCF MarginFCF / Revenue
0.9%
6.7%
Capex IntensityCapex / Revenue
1.0%
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$290.6M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASGN
ASGN
CBT
CBT
Q1 26
Q4 25
$102.3M
$126.0M
Q3 25
$83.9M
$219.0M
Q2 25
$124.9M
$249.0M
Q1 25
$16.8M
$73.0M
Q4 24
$100.2M
$124.0M
Q3 24
$135.8M
$204.0M
Q2 24
$90.7M
$207.0M
Free Cash Flow
ASGN
ASGN
CBT
CBT
Q1 26
$9.1M
Q4 25
$93.7M
$57.0M
Q3 25
$72.0M
$155.0M
Q2 25
$115.8M
$188.0M
Q1 25
$6.6M
$1.0M
Q4 24
$88.9M
$47.0M
Q3 24
$127.9M
$112.0M
Q2 24
$85.4M
$155.0M
FCF Margin
ASGN
ASGN
CBT
CBT
Q1 26
0.9%
Q4 25
9.6%
6.7%
Q3 25
7.1%
17.2%
Q2 25
11.3%
20.4%
Q1 25
0.7%
0.1%
Q4 24
9.0%
4.9%
Q3 24
12.4%
11.2%
Q2 24
8.3%
15.3%
Capex Intensity
ASGN
ASGN
CBT
CBT
Q1 26
1.0%
Q4 25
0.9%
8.1%
Q3 25
1.2%
7.1%
Q2 25
0.9%
6.6%
Q1 25
1.1%
7.7%
Q4 24
1.1%
8.1%
Q3 24
0.8%
9.2%
Q2 24
0.5%
5.1%
Cash Conversion
ASGN
ASGN
CBT
CBT
Q1 26
Q4 25
4.06×
1.73×
Q3 25
2.20×
5.09×
Q2 25
4.26×
2.47×
Q1 25
0.80×
0.78×
Q4 24
2.36×
1.33×
Q3 24
2.86×
1.49×
Q2 24
1.92×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASGN
ASGN

Segment breakdown not available.

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons